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Abstract
Dbl-related oncoproteins are guanine nucleotide exchange factors (GEFs) specific for Rho-family
GTPases and typically possess tandem Dbl (DH) and pleckstrin homology (PH) domains that act in
concert to catalyze exchange. Although the exchange potential of many Dbl-family proteins is
constitutively activated by truncation, the precise mechanisms of regulation for many Dbl-family
proteins are unknown. Tim and Vav are distantly related Dbl-family proteins that are similarly
regulated; their Dbl homology (DH) domains interact with N-terminal helices to exclude and prevent
activation of Rho GTPases. Phosphorylation, substitution, or deletion of the blocking helices relieves
this autoinhibition. Here we show that two other Dbl-family proteins, Ngef and Wgef, which like
Tim contain a C-terminal SH3 domain, are also activated by tyrosine phosphorylation of a blocking
helix. Consequently, basal autoinhibition of DH domains by direct steric exclusion using short N-
terminal helices likely represents a conserved mechanism of regulation for the large family of Dbl-
related proteins. N-Terminal truncation or phosphorylation of many other Dbl-family GEFs leads to
their activation; similar autoinhibition mechanisms could explain some of these events. In addition,
we show that the C-terminal SH3 domain binding to a polyproline region N-terminal to the DH
domain of the Tim subgroup of Dbl-family proteins provides a unique mechanism of regulated
autoinhibition of exchange activity that is functionally linked to the interactions between the
autoinhibitory helix and the DH domain.
The activation cycle of Rho GTPases1 is tightly controlled by three families of proteins:
GTPase-activating proteins (GAPs), guanine nucleotide dissociation inhibitors (GDIs), and
guanine nucleotide exchange factors (GEFs). The Dbl family of proteins constitutes the largest
group of GEFs specific for Rho GTPases. Dbl-family proteins are characterized by a Dbl
homology (DH) domain, which contacts the Rho GTPase to catalyze nucleotide exchange by
promoting and stabilizing an intermediate, nucleotide-free GTPase state, and an associated
pleckstrin homology (PH) domain, which fine-tunes the exchange process. The 69 human Dbl-
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family proteins are divergent in regions outside the DH/PH module and contain additional
protein domains that dictate unique cellular functions and regulate exchange activity (1).
Many Dbl-family proteins play a role in neuronal development. For example, Kalirin has been
shown to affect neurite outgrowth and both neuronal and dendritic spine morphogenesis (2).
In addition, P-rex was shown to be involved in neurotrophin-derived signaling and neuronal
migration (3). FRG (also known as FARP2 or FIR) is expressed in the ventricular zone during
mouse brain development and may play a role in neurogenesis, asymmetric cell division,
neuronal migration, and neurite remodeling (4). Plexin A1 binds to the N-terminal FERM
domain of FRG, and activation of plexin A1 by its ligand, semaphorin 3A, leads to an increase
in the exchange activity of FRG and subsequent growth cone collapse (5). Finally, Tiam1
binding to the polarity protein, Par3, spatially restricts this Dbl-family GEF to dendritic spines.
This restricted localization is required for dendritic spine morphogenesis (6).
Of the 69 human Dbl-family proteins, approximately one-third contain an SH3 domain in
addition to the DH/PH module, and many of these SH3 domain-containing Dbl-family proteins
also play a role in neuronal development. Several of these SH3 domain-containing Dbl-family
proteins also contain a proline rich region, indicating that intramolecular interactions between
an SH3 domain and a polyproline region may be one mechanism by which Dbl-family proteins
are autoinhibited. In fact, the Rac-specific exchange activity of Kalirin, which contains an SH3
domain between its two DH/PH cassettes, is negatively regulated by an intramolecular
interaction between that SH3 domain and three different polyproline-containing regions (7).
However, the Dbl-family proteins Asef and Intersectin-L, which contain SH3 domains N-
terminal to their DH/PH cassettes, are negatively regulated by SH3 domains directly binding
to the DH domain in a manner independent of the polyproline binding site of the SH3 domain
(8–10). Dbl-family GEFs, then, are able to be regulated by intramolecular interactions
involving SH3 domains in both polyproline-dependent and -independent manners.
Although many Dbl-family proteins are involved in diverse facets of neuronal development,
the mechanisms by which these proteins are regulated in this context are largely unknown. We
have recently shown that Tim, a small Dbl-family protein, is autoinhibited by a putative helix
N-terminal to the DH domain, which directly binds the DH domain to sterically exclude Rho
GTPases and prevent their activation. This autoinhibition is relieved by truncation or mutation
of the autoinhibitory helix or by a mutation on the conserved surface of the DH domain that
disrupts interactions with the autoinhibitory helix. Src and EphA4 phosphorylate Tim on two
tyrosines in the autoinhibitory helix, Tyr 19 and Tyr 22, which activates the exchange potential
of Tim. Finally, a peptide comprising the autoinhibitory helix is able to inhibit a truncated
version of Tim in trans (11).
Tim consists of an SH3 domain C-terminal to the DH and PH domains, and this domain
architecture is shared with a small group of Dbl-family members, including Wgef, Sgef, Vsm-
RhoGEF, neuroblastoma, and Ngef. In contrast to Vav and other Dbl-family members,
relatively little is known about the physiological importance and molecular regulation of this
subgroup. For example, Ngef is expressed primarily in the brain, is localized to chromosomal
region 2q37, and is transforming in cell culture (12,13). The mouse ortholog of Ngef, ephexin,
is expressed in the central nervous system during development and was originally cloned on
the basis of its ability to interact with the EphA4 receptor tyrosine kinase. Ephexin was shown
to activate RhoA, Rac1, and Cdc42 in cell-based assays and mediate ephrinA-induced growth
cone collapse (14). In addition, ephexin was shown to be phosphorylated by Src-family kinases
downstream of EphA4 receptor activation (13). Tyrosine phosphorylation enhances the ability
of ephexin to activate RhoA but does not affect its ability to activate Rac1 and Cdc42 (15).
Most recently, ephexin was shown to be phosphorylated in its N-terminus by Cdk5 downstream
of EphA4 receptor activation (16). The precise mechanism by which ephexin undergoes its
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specificity switch and the mechanisms by which Cdk5 and Src coordinate to modulate ephexin
activity are poorly understood.
Here we show that Ngef, like Tim, is regulated by phosphorylation of the autoinhibitory helix.
Unlike the case for ephexin, truncation, mutation, or phosphorylation of the autoinhibitory
helix activates the exchange potential of Ngef toward RhoA, Rac1, and Cdc42 in vitro and in
cell-based assays. In contrast to Tim, Ngef is phosphorylated by Src on only one of the tyrosines
in the autoinhibitory helix, and Ngef is not phosphorylated by EphA4. In addition, we show
that Ngef, like ephexin, interacts with and is phosphorylated downstream of signaling from
ligated EphA4. This phosphorylation leads to an increase in the exchange activity of Ngef
toward Rac1. Finally, we show that the related protein Wgef is similarly autoinhibited and
activated by phosphorylation. These results highlight a common mode of regulation shared by
Tim, Ngef, Wgef, and, likely, all members of the clade of Tim-related Dbl-family members.
In addition, we show that intramolecular interactions between the C-terminal SH3 domain of
Tim and a polyproline region immediately N-terminal to the DH domain are similarly
autoinhibitory. The SH3 domain of the Tim paralog, Ngef, functions in a manner similar to
that of Tim. These data demonstrate that the exchange potentials of Tim and its paralogs are
negatively regulated by two distinct intramolecular interactions, and each of these interactions
must be disrupted to fully activate these Dbl-family proteins.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Full-length and truncated versions of human Ngef and Wgef were PCR-amplified and ligated
into pET-21a (Novagen) between NdeI and XhoI in frame with a C-terminal, noncleavable
hexazhistidine tag. The cDNAs for these exchange factors were obtained as IMAGE clones
(ATCC) (accession numbers BC031573 and BC040640).
Both the Ngef and Wgef constructs were expressed in Escherichia coli strain BL21(DE3)
(Novagen). Cell cultures were grown at 37 °C in LB/ampicillin (100 µg/mL) and induced with
1 mM isopropyl β-D-thiogalactopyranoside (IPTG) for 5 h at 27 °C. Cell pellets were
resuspended in 20 mM Tris (pH 8), 300 mM NaCl, and 10% glycerol (buffer A) with 10 mM
imidazole, lysed using an Emulsiflex C5 cell homogenizer (Avestin), and clarified by
centrifugation at 40000g for 45 min at 4 °C. Clarified supernatants were loaded on a nickel-
charged metal chelating column (GE Healthcare) equilibrated with buffer A containing 10 mM
imidazole, washed with buffer A containing 50 mM imidazole, and eluted with buffer B
containing 400 mM imidazole. Eluted proteins were subsequently loaded onto an S-200 size
exclusion column equilibrated with 20 mM Tris (pH 7.5), 150 mM NaCl, 2 mM DTT, 1 mM
EDTA, and 5% glycerol. Fractions containing monomeric Ngef or Wgef were pooled,
concentrated, and stored at −80 °C. Mutations were introduced into wild-type Ngef or Wgef
using the Quikchange site-directed mutagenesis kit (Stratagene) as per the manufacturer’s
instructions, and these mutant proteins were expressed and purified as described above.
Mutations were also introduced into a pET-21a (Novagen) construct encoding full-length Tim
or Tim (Δ22) using the Quikchange site-directed mutatgenesis kit (Stratagene) by following
the manufacturer’s instructions. The PCR-amplified product for Tim (Δ57) was ligated into
pET-21a between NdeI and XhoI. These mutant Tim proteins were expressed and purified as
described previously (11). DNA sequences of all expression constructs were verified by
automated sequencing. RhoA, Cdc42, and Rac1 were purified as described previously (17–
19). The kinase domains of Src and EphA4 were also purified as described previously (11).
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Guanine Nucleotide Exchange Assays
Fluorescence spectroscopic analysis of incorporation of N-methylanthraniloyl (mant)-GTP
into RhoA was carried out as described previously (20). In brief, assay mixtures containing 20
mM Tris (pH 7.5), 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 100 µM mant-GTP (Molecular
Probes), and 2 µM RhoA were allowed to equilibrate with continuous stirring. After
equilibration, 400 nM Ngef or 50 nM Wgef was added and nucleotide loading was monitored
as the decrease in the tryptophan fluorescence (λex = 295 nm; λem = 335 nm) of RhoA or an
increase in mant-GTP fluorescence (λex = 360 nm; λem = 440 nm) as a function of time using
a Perkin-Elmer LS 55 spectrophotometer. Rates of guanine nucleotide exchange (kobs) were
determined from intrinsic tryptophan fluorescence data sets by fitting the data to a single-
exponential decay model with GraphPad Prism. Fold activation represents the ratio of kobs in
the presence of an exchange factor to the spontaneous nucleotide exchange rate for RhoA. Data
were normalized to yield percent GDP released, and assays were performed in duplicate.
Fluorescence spectroscopic analyses of release of mant-GTP from Cdc42 and Rac1 were also
carried out as described previously (20). In brief, assay mixtures containing 20 mM Tris (pH
7.5), 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 20 µM GTP, and 250 nM Rac1 or Cdc42
preloaded with mant-GTP were allowed to equilibrate with continuous stirring. After
equilibration, 400 nM Ngef was added and mant-GDP release was monitored as the decrease
in mant-GDP fluorescence (λex = 360 nm; λem = 440 nm) as a function of time. Rates of guanine
nucleotide exchange (kobs) were determined from the single-exponential decay best fits as
described above.
Cell Culture and Mammalian Expression Constructs
COS-7 cells were maintained in DMEM supplemented with penicillin/streptomycin and 10%
fetal bovine serum (Sigma). PCR-amplified Ngef or Wgef was ligated into pcDNA 3.1 Hygro
(Invitrogen) between EcoRI and XhoI such that an expressed HA tag was encoded at the N-
terminus of each construct. In addition, PCR-amplified HA-tagged Ngef was also ligated into
the pCIG2 vector (21), which contains a (cDNA)–IRES–eGFP complex under the control of
a CMV promoter and a chicken β-actin promoter, between EcoRI and XhoI. Mutations were
introduced into wild-type Ngef and Wgef as described above.
GTPase Activation Assays
Affinity purifications of RhoA, Rac1, and Cdc42 were carried out as described previously
(22). In brief, the Rho binding domains (RBDs) of Pak (amino acids 70–132) and Rhotekin
(amino acids 7–89) were expressed as a GST fusion proteins in BL21(DE3) cells and
immobilized on glutathione-coupled Sepharose 4B beads (GE Healthcare). COS-7 cells were
transiently transfected in 100 mm dishes with 12 µg of various pCIG2-Ngef constructs using
LipofectAMINE 2000 (Invitrogen) according to the manufacturer’s protocol. Immediately
post-transfection, these cells were serum starved in DMEM supplemented with 0.1% FBS and
incubated for 16 h. Cells were washed in ice-cold PBS and lysed in lysis buffer [50 mM Tris
(pH 7.5), 150 mM NaCl, 30 mM MgCl2, 1.0% Triton X-100, and protease inhibitors]. Lysates
were clarified by centrifugation at 16000 rpm for 10 min. The total protein concentration of
the lysates was determined by a colorimetric assay (Bio-Rad). One milligram of clarified
COS-7 lysate was incubated with 120 µg of GST-Pak-RBD beads for 1 h at 4 °C. The beads
were washed three times in lysis buffer. Total and affinity-purified lysates were subjected to
SDS-PAGE and Western blot analysis using anti-Cdc42 (Transduction Laboratories)
monoclonal antibodies. Each experiment was performed two or three times.
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The activated GEF assays were performed essentially as described previously (23). In brief,
nucleotide-free mutants of RhoA (G17A), Rac1 (G15A), and Cdc42 (G15A) were expressed
as GST fusion proteins in BL21 (DE3) cells and immobilized on glutathione-coupled
Sepharose 4B beads (GE Healthcare). COS-7 cells were transiently transfected in 100 mm
dishes with 12 µg of various pCIG2-Ngef constructs using LipofectAMINE 2000 (Invitrogen)
according to the manufacturer’s protocol. Immediately post-transfection, these cells were
serum starved in DMEM supplemented with 0.1% FBS and incubated for 16 h. Cells were
washed in ice-cold PBS and lysed in lysis buffer [20 mM Hepes (pH 7.5), 150 mM NaCl, 2
mM MgCl2, 1.0% Triton X-100, and protease inhibitors]. Lysates were clarified by
centrifugation at 16000 rpm for 10 min. The total protein concentration of the lysates was
determined by a colorimetric assay (Bio-Rad); 0.5 mg of clarified COS-7 lysate was incubated
with 120 µg of GST–GTPase beads for 1 h at 4 °C. The beads were washed three times in lysis
buffer. Total and affinity-purified lysates were subjected to SDS–PAGE and Western blot
analysis using anti-HA (Covance) monoclonal antibodies. Each experiment was performed
two or three times.
In Vitro Kinase Assay
Thirty micrograms of purified Ngef protein was incubated with 250 ng of recombinant Src or
EphA4 kinase domain in kinase buffer [100 mM Tris (pH 7.5) and 125 mM MgCl2]
supplemented with 100 µM ATP 30 min at 37 °C. Samples were subjected to SDS–PAGE and
immunoblot analysis using an anti-phosphotyrosine monoclonal antibody (BD Transduction
Laboratories).
Phosphorylation in COS-7 Cells
COS-7 cells were trans-fected with various combinations of pCIG2-HA-Ngef and murine
EphA4 (generous gift of K. Kullander, Uppsala Universitet, Uppsala, Sweden) using
LipofectAMINE 2000 (Invitrogen) according to the manufacturer’s protocol. Eighteen hours
post-transfection, the cells were serum starved and treated for 30 min with either 2 µg/mL
ephrin-A3-Fc (R&D Systems) that had been preclustered with human anti-Fc antibody or the
anti-Fc antibody itself. The cells were then lysed in 20 mM Tris (pH 7.5), 150 mM NaCl, 1
mM EGTA, 1 mM EDTA, and 1% Triton X-100 with protease inhibitor tablets (Roche). The
lysates were subjected to immunoprecipitation analysis using anti-HA-conjugated affinity
matrix (Roche) or GTPase activation assays.
Analytical Gel Filtration Chromatography
One milligram of purified full-length Tim was loaded onto a calibrated Superdex S-75 column
(GE Healthcare) in 100 µL of 20 mM Tris (pH 7.5), 300 mM NaCl, 2 mM DTT, 1 mM EDTA,
and 5% glycerol and was eluted at a flow rate of 0.5 mL/ min.
RESULTS
The Exchange Activity of Ngef toward Its Cognate GTPases Is Regulated by Autoinhibition
We have previously shown that the Dbl-family protein, Tim, is autoinhibited by a short,
putative helix N-terminal to its DH domain. Tim shares domain architecture and a high level
of sequence identity with five other human Dbl-family proteins: neuroblastoma, Sgef, Vsm-
RhoGEF, Wgef, and Ngef. All members of this subgroup possess a putative autoinhibitory
region N-terminal to the DH domain with a high degree of sequence identity to the short
autoinhibitory region mapped in Tim (Figure 1A). Consequently, it is likely that other members
of this subgroup are regulated in a manner similar to that of Tim, and we tested this hypothesis
with Ngef.
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The mouse ortholog of Ngef, ephexin, has been shown to activate RhoA, Rac1, and Cdc42 in
cell-based activity assays (14), and similarly, Ngef activated these GTPases in vitro (Figure
1B and Table 1). However, this activation required deletion of the putative autoinhibitory helix,
since a construct lacking this helix exhibited robust activity (Δ185) while the longer but still
N-terminally truncated form of Ngef (Δ166) and the full-length version (wt) were essentially
inert in RhoA, Rac1, and Cdc42 exchange assays. Furthermore, substitution of Tyr 179 with
Glu (Y179E) within the putative autoinhibitory helix activated Ngef to the same extent as
removing this region by truncation. The RhoA assays were performed by monitoring the
quenching of fluorescence of tryptophan residues intrinsic to RhoA upon binding of the
fluorescently labeled GTP, while the Rac and Cdc42 assays were performed by monitoring the
quenching of fluorescence of the prebound GTP analogue as it is replaced by unlabeled GTP.
These two assays involve differing concentrations of both GTPase and GEF; therefore, we
cannot use this experiment to determine the GTPase on which Ngef is most efficient at
exchange of guanine nucleotide. However, we do show that like Tim, Ngef is activated toward
its full repertoire of Rho GTPase substrates by removal or substitution of a small, conserved
segment with high helical propensity located N-terminal to its DH domain. Similar to the
correlation seen with Tim, the in vitro guanine nucleotide exchange activity of Ngef also
tracked with its capacity to transform NIH 3T3 cells (data not shown).
To confirm that the N-terminal region is necessary for Ngef inhibition in the context of an
intact cell, we performed affinity purifications of active Ngef using GST-tagged versions of
nucleotide-free RhoA, Rac1, and Cdc42 [RhoAG17A, Rac1 G15A, and Cdc42 G15A (Figure
2A)]. Since Dbl-family proteins bind preferentially to nucleotide-free Rho-family GTPases,
these constructs are expected to affinity purify any active GEF specific for these GTPases
present in a cell lysate. HA-tagged Ngef (Δ166), when expressed in serum-starved COS-7 cells,
did not appreciably interact with RhoA G17A, Rac1 G15A, or Cdc42 G15A. In contrast, Ngef
(Δ166+Y179E), in which a key tyrosine in the autoinhibitory helix is mutated, was affinity
purified by all three of the nucleotide-free GTPases, suggesting that the region of Ngef
immediately N-terminal to its DH domain, and Y179 in particular, leads to Ngef autoinhibition
by preventing its interaction with its cognate GTPases. These experiments were performed in
the context of Δ166 Ngef because full-length Ngef harboring the Y179E mutation expresses
inconsistently in COS-7 cells.
Affinity purification of active RhoA and Rac1 from the lysates of COS-7 cells (Figure 2B)
confirmed the direct correlation between the capacity of Ngef to activate RhoA and Rac1 in
vitro and in cells. Transfection of Ngef (Δ166+Y179E) into COS-7 cells significantly
stimulated loading of GTP onto endogenously expressed RhoA and Rac1 relative to the empty
vector. We were unable to detect anincrease in levels ofCdc42 · GTP due to Ngef (Δ166
+Y179E) expression (Figure 2B), indicating that either Ngef expression does not lead to Cdc42
activation in COS-7 cells or Ngef expression is associated with a transient activation of Cdc42
that we are unable to detect by affinity precipitation of steady-state levels of activated Cdc42.
Another Dbl-family protein, Dbs, has been shown to be an exchange factor specific for RhoA
and Cdc42 in vitro, but its expression in NIH 3T3 cells does not lead to an increase in the level
of Cdc42 · GTP as determined by affinity purification assays (24). Interestingly, a peptide
corresponding to the autoinhibitory helix of Tim (11) effectively inhibits both the RhoA and
Cdc42-specific exchange activity of Ngef in vitro (Figure 2C and data not shown), confirming
that Tim and Ngef are regulated similarly.
The Exchange Potential of Ngef Is Directly Activated by Src
Also like Tim, Ngef containing the autoinhibitory region (Δ166) was robustly phosphorylated
by Src in vitro, while further truncation (Δ185) to remove the autoinhibitory region led to loss
of phosphorylation by Src (data not shown). Since Tyr 179 and 182 are the only tyrosines
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removed by the larger truncation, these data indicate that Ngef (Δ166) is phosphorylated by
Src exclusively within the autoinhibitory region at either of these tyrosines or both.
Interestingly, mutation of Y179 led to a decrease in the level of Ngef phosphorylation by Src
(Figure 3A), while mutation of Y182 led to a substantial increase in the level of phosphorylation
of Ngef by Src. These data indicate that both Y179 and Y182 are important for the maintenance
of Ngef in the autoinhibited state, but in contrast to the situation described for Tim, only Y179
is a substrate for direct phosphorylation by Src.
Relative to its unphosphorylated form, phosphorylation of Ngef (Δ166) by Src led to an 8-fold
increase in the rate of catalyzed guanine nucleotide exchange using RhoA as a substrate in
vitro (Figure 3B and Table 2). This increase in the guanine nucleotide exchange rate due to
Src phosphorylation is relatively modest due to the fact that only approximately 10% of the
Ngef input is estimated to be phosphorylated in the in vitro kinase assay (data not shown).
Using Cdc42 as the substrate, the equivalent enhancement was 3-fold (Table 2). Reminiscent
of the situation with Tim, Src most likely also forms a metastable complex with Ngef, since
Src in the absence of ATP was able to stimulate guanine nucleotide exchange catalyzed by
Ngef (Δ166) approximately 3- and 1.5-fold for RhoA and Cdc42 substrates, respectively. These
rate enhancements required both Ngef and Src since the kinase alone is incapable of stimulating
exchange with either RhoA or Cdc42 (Figure 3B and Table 2). Interestingly, and in contrast
to Tim, Ngef is neither directly phosphorylated nor activated by the kinase domain of EphA4
in vitro (Table 2 and data not shown).
Ngef Interacts with and Is Phosphorylated Downstream of EphA4
We have established that Ngef is directly tyrosine phosphorylated by Src in the autoinhibitory
helix. However, ephexin, the mouse ortholog of Ngef, is known to be tyrosine phosphorylated
in a Src-dependent manner as a consequence of EphA4 stimulation. To determine if Ngef also
interacts with EphA4 and is phosphorylated as a result of EphA4 stimulation, we performed
co-immunoprecipitation experiments from COS-7 cells overexpressing both Ngef and EphA4
(Figure 4). Overexpression of EphA4 in COS-7 cells leads to significant autophosphorylation
and activation of this receptor tyrosine kinase in the absence of exogenous ephrin A3 ligand
(data not shown). This situation presumably arises due to spontaneous clustering and
transactivation of over-expressed EphA4 receptors. In the same vein, Ngef is significantly
tyrosine phosphorylated when coexpressed with EphA4 in either the presence or absence of
exogenous ephrin A. Furthermore, Ngef and EphA4 were shown to interact without the
application of ephrin A (Figure 4A).
Despite the pluripotent capacity of ephexin to activate Cdc42, Rac1, and RhoA, it has been
reported that EphA4-and Src-dependent tyrosine phosphorylation of ephexin results primarily
in RhoA activation in vivo (15). Therefore, the capacity of EphA4 to restrict the exchange
profile of Ngef by phosphorylation was also tested. Various combinations of Ngef and EphA4
were transfected into COS-7 cells prior to affinity purification of active Rac (Figure 4B). These
cells were not treated with ephrin A3 since it was shown earlier that overexpressed EphA4
constitutively phosphorylates Ngef under these conditions. Transfection of EphA4 and Ngef
significantly stimulated loading of GTP onto Rac1 compared to transfection of Ngef alone
(Figure 4B), indicating that Ngef is able to activate Rac1 when stimulated by EphA4 in the
context of an intact cell.
Wgef Is Similarly Regulated by Autoinhibition and Phos-phorylation
The studies described above establish that Ngef is regulated like Tim in that Ngef possesses a
putative helical motif that is required for autoinhibition and that this autoinhibition is relieved
by phosphorylation of the helical motif. To extend this mode of regulation to other Tim-related
members, Wgef was studied. Wgef is expressed primarily in liver, heart, and kidney and
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activates RhoA, Rac1, and Cdc42 in cell-based activity assays (25) but is specific for RhoA
and Cdc42 in vitro (26). Truncation of the autoin-hibitory helix of Wgef (Δ302) is activating
in vitro and in affinity purification assays using nucleotide-free RhoA as the affinity matrix
(Figure 5A,B). In addition, Wgef behaved like Tim and Ngef in that mutation of its
autoinhibitory helix (Y295E, analogous to Y19E in Tim; Y179E in Ngef) activated a truncated
form of Wgef (Δ285) containing the autoinhibitory region (Figure 5A and Table 3). Also, it
was previously shown that mutation of the DH domain of Tim (S114A) designed to disrupt
specifically interactions with its autoinhibitory helix was activating and similar mutation of
Wgef (Δ285+S394A) was also activating. Interestingly, Wgef (Δ302+S239A) has a slower
rate of exchange than Wgef (Δ302), indicating that this residue may be important for the DH
domain of Wgef engaging RhoA as well as for engaging the autoinhibitory helix. The analogous
mutation in Ngef (Δ166+S291A) was insoluble in E. coli, and thus, the activity of this mutant
protein could not be assessed. Moreover, Wgef, like Tim and Ngef, is inhibited by a peptide
derived from the autoinhibitory helix of Tim (Figure 5C). Wgef is also similar to Tim in its
activation by both Src and EphA4 phosphorylation in vitro (Figure 5D and Table 3), while
Ngef is only directly activated by Src (Figure 2B and Table 2). These data indicate that
autoinhibition mediated by short helical motifs and autoinhibition relieved by phosphorylation
are general mechanisms of regulation for Tim and related Dbl-family members.
Tim Is Autoinhibited by a Proline-Containing Region in Its N-Terminus
The N-terminus of Tim consists of an extended region of low complexity and no known domain
structure. Truncation of the 22 N-terminal amino acids of Tim leads to a robust increase in its
exchange activity in vitro (11). To determine if additional regions of the Tim N-terminus play
a role in its regulation, we tested the exchange activity of Tim mutants in which the N-terminus
had been further truncated. A shorter version of Tim [Δ57 (Figure 6 and Table 4)] was able to
catalyze nucleotide exchange on RhoA 45% more efficiently than the previously characterized
Tim (Δ22). Further N-terminal truncations destabilized Tim upon overexpression in E. coli
(data not shown), most likely reflecting the loss of important secondary structural elements
necessary for the integrity of the extended DH domain, which begins at residue 70 in full-length
Tim. This DH domain extension is also observed in two RhoA-specificDbl-familyproteins,
LARGandPDZ-RhoGEF(27,28).
Primary sequence analysis (Figure 6A) indicated that the region of Tim between residues 23
and 57 contains a polyproline sequence that fits the consensus for type 1A ligands of SH3
domains, namely PXФXXPXXP, where P represents proline, X represents any amino acid,
and Ф represents a hydrophobic amino acid (29). To test if the integrity of this region is
important for maintenance of Tim autoinhibition, prolines within this sequence were
individually mutated to alanine within the context of both full-length Tim and Tim (Δ22), and
the mutated proteins were tested for an elevated capacity to activate RhoA in vitro. Tim (Δ22
+P49A), similar to Tim (Δ57), was approximately 45% more efficient at catalyzing nucleotide
exchange than Tim (Δ22) (Figure 6B and Table 4). P49A Tim was itself 3-fold more efficient
than wild-type Tim at catalyzing nucleotide exchange (data not shown). Mutation of either
proline 46 or proline 52 to alanine had no effect on the exchange potential of full-length Tim
or Tim (Δ22) (Table 4 and data not shown). These data indicate that the polyproline region of
Tim, proline 49 in particular, is involved in the regulation of Tim by autoinhibition.
The SH3 Domain of the Tim-Related Proteins Is Involved in Their Autoinhibition
Tim clusters with five other human Dbl-family proteins, neuroblastoma, Sgef, Wgef, Ngef,
and Vsm-RhoGEF, on the basis of the high level of sequence identity among DH domains and
overall domain architecture that includes an SH3 domain carboxyl-terminal to the canonical
DH/PH module. While not readily evident using standard sequence alignment algorithms such
as PSI-BLAST, three other members of this subgroup, namely, Ngef, Wgef, and Vsm-RhoGEF,
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possess a proline rich region with sequence homology to the polyproline region of Tim shown
above to mediate Tim autoinhibition and engagement of its SH3 domain (Figure 6A). Because
the polyproline region in the N-terminus was determined to be required for Tim autoinhibition,
we wanted to test the hypothesis that the C-terminal SH3 domain and the N-terminal
polyproline region are involved in an intramolecular SH3 domain–ligand interaction. Our
preliminary data indicate that the isolated GST-tagged SH3 domain of Tim interacts with full-
length Tim in affinity purification assays and that an untagged version of the SH3 domain is
able to interact with a peptide comprised of the polyproline region of Tim (data not shown).
We therefore wanted to ask if the SH3 domain of Tim was important for its autoinhibition. We
were unable to assess the consequences of removal of the SH3 domain on the in vitro exchange
activity of Tim, since both truncation of the SH3 domain and mutation of a conserved
tryptophan (W470R) known to be critical for polyproline ligand binding destabilized Tim upon
overexpression in E. coli (data not shown). In addition, expression of Tim (Δ22+W470R) in
NIH 3T3 cells did not induce formation of foci relative to background levels, despite the fact
that Tim (Δ22) did induce formation of foci in the same experiment (data not shown). Given
these results, it seems likely that forms of Tim mutated within its SH3 domain are unstable in
vivo as well as in vitro.
To assess whether the SH3 domain of Tim mediated intramolecular interactions or possibly
homo-oligomerization, we performed an analytical gel filtration chromatography experiment
(Figure 6C). Tim eluted as a single peak from this column at a volume corresponding to 60
kDa. These data indicate that Tim is 100% monomeric in solution. Because this experiment
was performed at a Tim concentration higher than the binding affinity of a physiologically
relevant intermolecular interaction (166 µM), it is likely that the SH3 domain of Tim
contributes to its autoinhibition through intramolecular, rather than intermolecular,
interactions.
Similar to the case of Tim, removal of the SH3 domain of Ngef renders the protein inactive in
vitro (data not shown). Therefore, to test if this domain plays a role in the autoinhibition of
Ngef, we introduced a point mutation (W649R) in the context of truncated, active Ngef (Δ185)
that is expected to abrogate the ability of this domain to bind polyproline-containing ligands
(30). The W649R mutation led to an approximately 2-fold increase in the exchange activity of
Ngef (Δ185) in vitro (Figure 6D and Table 4), suggesting that an interaction between the C-
terminal SH3 domain and the N-terminal polyproline region of Ngef plays a role in regulating
the exchange activity of Ngef.
DISCUSSION
A model for the regulation of Tim and related GEFs by intramolecular and intermolecular
interactions is depicted in Figure 7. In the basal state (left), the exchange potential of the GEF
is autoinhibited by two sets of intramolecular interactions: (i) the autoinhibitory helix packing
into a conserved pocket on the DH domain and (ii) the SH3 domain binding to the N-terminal
polyproline region. These two sets of interactions are mutually cooperative and serve to tightly
suppress access of Rho GTPases to the surface of the DH domain needed to catalyze guanine
nucleotide exchange. Binding of another protein to the SH3 domain, with an affinity higher
than that of the intramolecular interaction, would remove the SH3 domain from that polyproline
region (center). This binding interaction could also localize the GEF to the appropriate
subcellular compartment for nucleotide exchange. Interactions between another as yet
unidentified protein and the polyproline region of the GEF would similarly serve to modulate
GEF activity and localization.
With interactions between the SH3 domain and the polyproline region disrupted, interaction
of the autoinhibitory helix with the DH domain would be destabilized, increasing the frequency
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that the autoinhibitory helix is solvent-exposed. Src could then phosphorylate the tyrosine
residues in the autoinhibitory helix as previously described (11), both preventing a rebinding
event and fully activating the exchange potential of this Dbl-family GEF (Figure 7, right panel).
Activation of Rho GTPases downstream of transmembrane receptors such as Ephs occurs
through either inactivation of GAPs or activation of GEFs. While EphB receptors are able to
interact with Intersectin (31), Kalirin (2), and Vav2 (32), the best-characterized interaction
between an EphA receptor and a Dbl protein is that of EphA4 and ephexin. Ephexin is tyrosine
phosphorylated in an N-terminal motif with a significant degree of sequence identity to the
autoinhibitory helix described here for Ngef and related Dbl-family members. Phosphorylation
of ephexin in this motif is reported to change the specificity of this GEF for cognate GTPases.
Specifically, when ephexin was not tyrosine phosphorylated, it activated RhoA, Rac1, and
Cdc42, but when ephexin was tyrosine phosphorylated, ephexin activated RhoA exclusively
(15). These results, based largely upon examination of the cellular morphology of fibroblasts
transiently transfected with mutants of ephexin and EphA4, are in contrast to those shown here.
We have used in vitro guanine nucleotide exchange assays and cell-based GTPase activity
assays to show mechanistically that phosphorylation or phosphomimetic mutation of Ngef
leads to an activation of the exchange potential of this GEF toward all three GTPases that were
studied: RhoA, Rac1, and Cdc42. This discrepancy between human Ngef and it mouse
ortholog, ephexin, could be explained in several different ways. First, phosphorylated Ngef
may be differentially localized in the growth cone to activate Rac1 and Cdc42 in restricted
microdomains. High-resolution microscopy studies examining the intracellular localization of
phosphorylated Ngef and the activated cognate GTPases need to be carried out to examine this
idea. Second, ephrin A binding to EphA4 could independently activate an as yet unidentified
GAP for Rac1 and Cdc42 such that the net result of this signaling pathway is a preferential
activation of RhoA. Finally, activation of Rac1 and Cdc42 by Ngef could play a role in growth
cone collapse. Rac1 activity has been shown to be required for growth cone collapse since it
promotes internalization of the Eph-ephrin complex from the plasma membrane (32,33).
Additionally, active Rac1 and Cdc42 are critical for axon retraction, branching, and
defasiculation following growth cone collapse (34). The role of Ngef in these processes has
yet to be determined.
Further work is necessary to identify potential intermolecular binding partners for the SH3
domains and polyproline regions of the members of this subfamily. One potential binding
partner for the polyproline region of Tim is the SH3 domain of Src itself. In this scenario, the
interaction between Src and the polyproline region of Tim would relieve the autoinhibitory
interactions between the SH3 domain of Src and its intramolecular ligand in the SH2 kinase
linker, thus allowing the kinase domain to phosphorylate and activate Tim. This positive
feedback loop would allow for rapid, specific activation of Tim.
Phenotypic diversity and complexity in biological systems often arise from new combinations
of proteins and independently folding protein domains working together in networks, and not
from de novo generation of new protein functions (35). In fact, multiple-sequence analysis of
Dbl-family proteins from diverse animal species revealed that GEFs are composed of an N-
terminal SH3 domain followed by a DH/ PH cassette, such as Asef, and GEFs are composed
of a DH/PH cassette followed by an SH3 domain, such as Tim, evolved from a common
ancestor composed of only a DH/PH cassette through independent insertion of the SH3 domain
(36). Since the SH3 domains of both Tim and Asef function to regulate the exchange potential
of these GEFs by autoinhibition, it is likely that the evolutionary pressure for the insertion of
the SH3 domain was to achieve finer control of the exchange activity of these Dbl-family
proteins.
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The stabilization of the autoinhibitory motif on the DH domain of Tim by intramolecular
interactions between the SH3 domain and polyproline regions, like the autoinhibitory motif
itself, is reminiscent of the mechanism of autoinhibition of the Vav isozymes. For example,
recent structural characterization of full-length Vav3 by electron microscopy showed that the
CH domain of this protein stabilizes the acidic region, including the autoinhibitory helix,
through intramolecular interactions with the zinc finger domain (37). For both the Tim and
Vav subfamilies, then, multiple domains are functioning together to stabilize the inactive state
of the catalytic DH domain. While the first set of interactions involving the autoinhibitory helix
is conserved between the Tim and Vav subfamilies (11), the second set of interactions is
divergent in both primary and tertiary structure. If autoinhibition by interaction of the
autoinhibitory helix with the DH domain is a conserved mechanism of regulation among Dbl-
family GEFs, it seems likely that the second, cooperative set of stabilizing interactions dictates
the activating inputs and fine-tunes the dynamics of the guanine nucleotide exchange process.
In this sense, the two sets of autoinhibitory interactions with Tim and Vav approximate a logical
AND gate (38). Ultimately, full activation of these Dbl-family proteins cannot occur until both
sets of autoinhibitory interactions are removed, thus allowing a large degree of spatiotemporal
control over the activation of GTPases by Dbl-family proteins. We anticipate similar
coordinated regulation to be found in other members of the Dbl family.
In conclusion, we have demonstrated that Ngef is activated toward its full repertoire of cognate
GTPases, namely RhoA, Rac1, and Cdc42, by removal, substitution, or Src-dependent tyrosine
phosphorylation of a small, conserved sequence N-terminal to its DH domain. Similarly,
EphA4-dependent phosphorylation of Ngef promotes the activation of multiple Rho GTPases.
Ngef exchange activity is inhibited by a peptide derived from the autoinhibitory sequence of
the related protein, Tim, indicating that these two proteins are regulated in a nearly identical
manner. A third member of this subfamily, Wgef, is regulated similarly. Tim, Ngef, and Wgef
cluster with Sgef, Vsm-RhoGEF, and neuroblastoma on the basis of common domain
architecture and sequence similarity. Given that each of these Dbl-family members shares
highly conserved autoinhibitory motifs, it is highly likely that all members of this clade are
regulated by steric occlusion of their DH domains by short helical motifs and that this
autoinhibition is relieved physiologically by phosphorylation of these motifs. Finally, we have
identified a second mechanism of autoinhibition that is likely to be conserved among the
members of this clade, which is mediated by interactions between the C-terminal SH3 domain
and N-terminal polyproline region and may function to increase the degree of spatiotemporal
control over the activation of the Tim-related proteins.
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FIGURE 1. Ngef is regulated by autoinhibition
(A) The N-terminal portions of Ngef and its closest homologues are highlighted in the multiple-
sequence alignment. Colored bars bordering the alignment demark regions in Ngef
corresponding to the autoinhibitory helix (red), an intervening region (green), and the start of
the DH domain (yellow). Tyrosines 179 and 182 of Ngef are numbered. The region in Ngef
and its close homologues that is strongly predicted to be helical using standard algorithms is
indicated (α). The peptide inhibitor used in Figure 2C and Figure 5C was derived from the
autoinhibitory helix of Tim (SQLLYQEYSDV). The position of the DH domain mutation
described in Figure 5A is also indicated (asterisk). The domain architecture of Ngef and its
closest homologues is shown above the alignment. (B) Full-length (wt) and truncated (Δ166)
forms of Ngef that retain the conserved autoinhibitory helix modestly activate RhoA, Rac1,
and Cdc42. In contrast, Ngef forms in which the autoinhibitory helix is truncated (Δ185) or
mutated (Y179E) have dramatically enhanced capacities to catalyze nucleotide exchange on
all three GTPases. The RhoA assays monitor the quenching of tryptophan fluorescence due to
mant-GTP binding and use 400 nM GEF and 2 µM GTPase, while the Rac1 and Cdc42 assays
monitor the quenching of mant-GTP fluorescence as it is released into solution and use 400
nM GEF and 250 nM GTPase. Equal amounts (5 µg) of purified proteins used in the exchange
assays are shown at the bottom right following SDS–PAGE and staining with Coomassie
brilliant blue.
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FIGURE 2. Form of Ngef in which the Autoinhibitory Helix is Mutated is Activated in Cell-Based
Assays
(A) The activity of Ngef constructs transiently expressed in quiescent COS-7 cells was assessed
by a pull-down assay using GST-tagged nucleotide-free RhoA, Rac1, or Cdc42 as the affinity
purification matrix. Levels of active Ngef were determined by immunoblotting the pull-down
samples. Immunoblots of the total cell lysate (2.5% input shown) show approximately equal
expression of the Ngef constructs (n.s., nonspecific). The experiments were performed three
times, and representative examples are shown. (B) Expression constructs for the
phosphomimetic form of Ngef or vector alone were transfected into COS-7 cells, which were
subsequently serum starved in DMEM supplemented with 0.1% FBS for 16 h prior to affinity
purification of active Rho GTPases with the effector domain of either Rhotekin (RTK) or PAK.
The levels of active and total GTPases were determined by immunoblotting. In the same
experiment, expression of the HA-tagged Ngef variant was verified by immunoblotting (n.s.,
nonspecific). The experiments were performed three times, and representative examples are
shown. (C) Ngef (Δ185) was incubated with a peptide corresponding to the N-terminal
autoinhibitory region of Tim (WT, biotin-SQLLYQEYSDV-amide) or a mutant peptide (MT,
biotin-SQLLEQEYSDV-amide) at room temperature for 20 min. The resulting complexes
were assayed for their ability to stimulate loading of mant-GTP onto RhoA. The peptide
concentrations were 100 µM.
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FIGURE 3. Phosphorylation by Src directly activates Ngef
(A) Src specifically phosphorylates tyrosine 179 within the autoinhibitory helix of Ngef.
Purified forms of Ngef were incubated with recombinant Src and ATP for 30 min prior to SDS-
PAGE (bottom panel), and immunoblotting was used to assess levels of phosphorylation (top
panel). Substitution of Tyr 179 abrogates phosphorylation. This image represents a composite
of several gels. (B) Phosphorylation of Ngef by Src promotes the capacity of Ngef to catalyze
nucleotide exchange on RhoA. Ngef (Δ166) was incubated with combinations of kinase and
ATP as indicated for 30 min prior to the addition of the mixtures to exchange reaction mixtures.
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FIGURE 4. Ngef is phosphorylated and activated upon stimulation of EphA4
(A) Ngef (Δ166) is phosphorylated when coexpressed with EphA4 in COS-7 cells, either in
the presence or in the absence of ephrin A3-Fc ligand preclustered with anti-Fc antibody
(ephrinA3+Fc) as determined by immunoprecipitation of HA-Ngef and performance of
immunoblot experiments using an anti-phosphotyrosine antibody (top panel). The bands
resulting from phosphorylated Ngef (p-Ngef) and the IgG heavy chain (h.c.) are indicated. In
addition, EphA4 interacts with Ngef as determined by immunoblotting these same
immunoprecipitation reaction mixtures with an anti-EphA4 antibody (BD Transduction
Laboratories; bottom panel). In the same experiment, expression of HA-Ngef and EphA4 was
verified (middle panels; 2.5% input shown). (B) COS-7 cells were cotransfected with various
combinations of HA-Ngef (Δ166) and EphA4 and serum starved prior to affinity purification
of active Rac1. The levels of active and total GTPases were determined by immunoblotting.
In the same experiment, expression of the HA-tagged Ngef variant and EphA4 was verified.
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FIGURE 5. Wgef is regulated by autoinhibition and phosphorylation
(A) The exchange of GDP bound to RhoA and catalyzed by 50 nM Wgef was assessed using
a standard fluorescence-based assay (17,20). Equal amounts (2 µg) of purified proteins used
in the exchange assays are shown at the right following SDS–PAGE and staining with
Coomassie brilliant blue. (B) The activity of Wgef constructs transiently expressed in quiescent
COS-7 cells was assessed by a pull-down assay using GST-tagged nucleotide-free RhoA as
the affinity purification matrix. Levels of active Wgef were determined by immunoblotting the
pull-down samples. Immunoblots of the total cell lysate (2.5% input shown) show
approximately equal expression of the Wgef constructs. (C) Wgef (Δ302) was incubated with
either a peptide corresponding to the N-terminal autoinhibitory region of Tim (WT, biotin-
SQLLYQEYSDV-amide) or a mutant peptide (MT, biotin-SQLLEQEYSDV-amide) at room
temperature for 20 min. The resulting complexes were assayed for their ability to stimulate
loading of mant-GTP onto RhoA. The peptide concentrations were 100 µM, and the Wgef
concentrations were 50 nM. (D) Phosphorylation of Wgef by Src promotes the capacity of
Wgef to catalyze nucleotide exchange on RhoA. Autoinhibited Wgef (Δ285) was incubated
with combinations of kinase and ATP as indicated for 30 min prior to addition of the mixtures
to exchange reaction mixtures.
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FIGURE 6. Intramolecular interaction between the SH3 domain and the N-terminal polyproline
region negatively regulates the exchange potential of Tim and Ngef
(A) Multiple-sequence alignment of the polyproline regions found in Tim and related GEFs.
Positions 22, 49, and 57 of human Tim are indicated above the alignment. (B) In vitro exchange
assays indicate that removal (Δ57) or substitution (Δ22+P49A) of the polyproline region of
Tim is activating. Purified proteins (5 µg) used in all exchange assays are shown at the right
after SDS–PAGE and staining with Coomassie brilliant blue. (C) Purified Tim at an initial
concentration of 166 µM elutes from an analytical gel filtration column as a single peak at a
volume corresponding to a molecular mass of 60 kDa. Both the chromatogram (top panel) and
SDS–PAGE analysis of the resulting fractions (bottom panel) are shown. (D) In vitro exchange
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assays indicate that Ngef (µ185) possesses an activated exchange potential relative to the
spontaneous loading (black trace) of guanine nucleotides onto Cdc42; W649R further activates
Ngef (Δ185). Equal amounts (5 µg) of purified proteins used in the exchange assays are shown
in the bottom panel following SDS-PAGE and staining with Coomassie brilliant blue.
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Model for the regulation of Tim and its paralogs by intramolecular and intermolecular
interactions. In the basal state (left), the exchange potential of Tim is autoinhibited by two sets
of intramolecular interactions. First, the autoinhibitory helix (red) packs against a conserved
pocket on the DH domain. Second, the SH3 domain binds to the N-terminal polyproline region.
This second set of interactions both stabilizes the autoinhibitory helix on the DH domain and
potentially occludes the DH domain. Intermolecular competition by an unknown protein
(purple) disrupts the intramolecular association of the SH3 domain for the polyproline region
(center) to increase the rate of dissociation of the autoinhibitory helix from the DH domain.
The increased solvent exposure of the autoinhibitory helix favors phosphorylation by Src,
thereby preventing reassociation of the autoinhibitory helix with the DH domain and fully
activating the exchange potential of Tim (right).
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Table 3











Wgef Src ATP kobs (×10
−3 s−1) fold stimulation
− − − 0.04 1.00
+ − − 0.09 2.06
+ − + 0.11 2.52
+ + − 0.13 3.12
+ + + 0.31 7.36
− + + 0.05 1.14
RhoA
Wgef EphA4 ATP kobs (×10
−3 s−1) fold stimulation
+ + − 0.05 1.11
+ + + 0.19 4.47
− + + 0.08 1.86
a
An analysis of the representative exchange data presented in Figure 5A, is shown. kobs and fold stimulation were calculated as described in Table 1.
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